<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02813538</url>
  </required_header>
  <id_info>
    <org_study_id>HGUGregorioMaranonCRH2AT</org_study_id>
    <nct_id>NCT02813538</nct_id>
  </id_info>
  <brief_title>Major Liver Resection: Early Clotting Disorders and Functional Impairment.</brief_title>
  <official_title>Hypercoagulability and Liver Function After Major Liver Resection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital General Universitario Gregorio Marañon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital General Universitario Gregorio Marañon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to evaluate early clotting disorders through thromboelastogram and
      anticoagulant proteins levels (maybe also endothelial markers) and liver function by
      indocyanine green clearance after major liver resection and search for a potential
      relationship between them.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2016</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">October 2016</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Years</target_duration>
  <primary_outcome>
    <measure>Establish a relationship between ICG and MCF</measure>
    <time_frame>1 week</time_frame>
    <description>We aim to find a potential association between ICG and MCF measured by thromboelastometry in the first week after surgery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Establish a relationship between pro and anticoagulant proteins levels and endothelial markers</measure>
    <time_frame>1 week</time_frame>
    <description>We aim to find a potential association between procoagulant factor levels, protein C,S and ATIII with thrombomodulin, heparan sulfate and syndecan-1 in the first week after surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Study blood coagulation disorders after major liver surgery resection</measure>
    <time_frame>2 years</time_frame>
    <description>We aim to characterize blood coagulation disorders during the first week after major liver surgery in our sample of patients</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Study liver function after major liver surgery</measure>
    <time_frame>2 years</time_frame>
    <description>We aim to study the predictive value of indocyanine green clearance for liver impairment after major liver surgery in our sample of patients</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Hepatic Insufficiency</condition>
  <condition>Blood Coagulation Disorders</condition>
  <arm_group>
    <arm_group_label>IGC and thromboelastometry</arm_group_label>
    <description>Patients that have hyper, normo o hypcoagulability measured by tromboelastometry and anticoagulant proteins levels early after major liver resection and clinical evolution and patients with liver funcion impairment or without it, measured by indocyanine green clearance early after surgery and clinical evolution</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Indocyanine green clearance</intervention_name>
    <description>To evaluate liver function by injection of indocyanine green by a peripheral vein and measure its clearance</description>
    <arm_group_label>IGC and thromboelastometry</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Thromboelastometry</intervention_name>
    <description>To evaluate blood coagulation impairment by obtaining blood sample from a peripheral vein and measure anticoagulant proteins levels plus obtaining thromboelastometry</description>
    <arm_group_label>IGC and thromboelastometry</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood samples for anticoagulant proteins levels analysis and thromboelastometry
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing major liver surgery defined as resection of 3 or more hepatic segments
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing major liver surgery defined as resection of 3 or more hepatic
             segments

        Exclusion Criteria:

          -  Indocyanin green allergy

          -  Thyrotoxicosis

          -  Thrombophilia

          -  Lupus anticoagulant

          -  Coagulation factor deficiency

          -  Venous thromboembolism in the last 3 years

          -  Pulmonary thromboembolism in the last 3 years
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Patricia Duque, MD, PhD</last_name>
    <phone>+34 646 664 465</phone>
    <email>patriduque@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jose Maria Perez, MD, PhD</last_name>
    <phone>+34 646 977 392</phone>
    <email>jppena@salud.madrid.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Gregorio Marañon Hospital</name>
      <address>
        <city>Madrid</city>
        <zip>28007</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patricia Duque, MD, PhD</last_name>
      <phone>+34 646 664 465</phone>
      <email>patriduque@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Jose Perez, MD, PhD</last_name>
      <phone>+34 646 977 392</phone>
      <email>jppena@salud.madrid.org</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 22, 2016</study_first_submitted>
  <study_first_submitted_qc>June 22, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 27, 2016</study_first_posted>
  <last_update_submitted>July 16, 2016</last_update_submitted>
  <last_update_submitted_qc>July 16, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 19, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital General Universitario Gregorio Marañon</investigator_affiliation>
    <investigator_full_name>Patricia Duque González</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Thrombelastography</keyword>
  <keyword>Antithrombin proteins</keyword>
  <keyword>Liver surgery</keyword>
  <keyword>Liver function tests</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Blood Coagulation Disorders</mesh_term>
    <mesh_term>Hemostatic Disorders</mesh_term>
    <mesh_term>Hepatic Insufficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Extracts</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Publishing results</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

